Societal CDMO Inc
F:RAH

Watchlist Manager
Societal CDMO Inc Logo
Societal CDMO Inc
F:RAH
Watchlist
Price: 1.58 EUR Market Closed
Market Cap: 165.5m EUR
Have any thoughts about
Societal CDMO Inc?
Write Note

Relative Value

The Relative Value of one RAH stock under the Base Case scenario is 1.52 EUR. Compared to the current market price of 1.58 EUR, Societal CDMO Inc is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RAH Relative Value
Base Case
1.52 EUR
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
Median 3Y
1.7
Median 5Y
1.7
Industry
2.6
Forward
1.8
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-7.9
Industry
23
Forward
-19.4
vs History
vs Industry
Median 3Y
-56.8
Median 5Y
-56.8
Industry
17.8
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-6.4
Industry
25.4
vs History
27
vs Industry
Median 3Y
2.8
Median 5Y
2.8
Industry
2.2
vs History
83
vs Industry
Median 3Y
1.9
Median 5Y
1.9
Industry
2.8
Forward
1.8
vs History
41
vs Industry
Median 3Y
8.9
Median 5Y
8.9
Industry
5.4
vs History
41
vs Industry
Median 3Y
25.9
Median 5Y
25.9
Industry
13.7
Forward
11.5
vs History
vs Industry
Median 3Y
-21.9
Median 5Y
-21.9
Industry
17.2
Forward
-129
vs History
vs Industry
Median 3Y
-94.6
Median 5Y
-94.6
Industry
16.5
vs History
vs Industry
Median 3Y
-18.6
Median 5Y
-18.6
Industry
19.3
vs History
75
vs Industry
Median 3Y
1.2
Median 5Y
1.2
Industry
2

Multiples Across Competitors

RAH Competitors Multiples
Societal CDMO Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Societal CDMO Inc
F:RAH
165.7m EUR 1.9 -13.4 31.8 -47.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
789.8B USD 19.3 94.4 50.6 56.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.8 24.2 27.6
US
Johnson & Johnson
NYSE:JNJ
374.3B USD 4.3 25.5 12.3 16
US
Merck & Co Inc
NYSE:MRK
261B USD 4.1 21.5 13.6 16.8
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
181.7B CHF 4.2 12.8 10.2 15.1
UK
AstraZeneca PLC
LSE:AZN
153.5B GBP 4 30.8 169.1 253.4
IE
Endo International PLC
LSE:0Y5F
154.4B USD 66.6 -52.8 247.3 620.1
P/E Multiple
Earnings Growth
US
Societal CDMO Inc
F:RAH
Average P/E: 34
Negative Multiple: -13.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
94.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.8
86%
US
Johnson & Johnson
NYSE:JNJ
25.5
-22%
US
Merck & Co Inc
NYSE:MRK
21.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.8
21%
UK
AstraZeneca PLC
LSE:AZN
30.8
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -52.8 N/A

See Also

Discover More
Back to Top